Overview
- The study published in EMBO Molecular Medicine compared blood samples from 1,455 ME/CFS patients with those of 131,000 healthy controls to uncover potential diagnostic markers.
- Researchers pinpointed 116 biomarkers linked to chronic inflammation, insulin resistance and liver dysfunction in individuals with ME/CFS.
- Patients reporting post-exertional malaise showed the most pronounced biomarker differences, underscoring a unique physiological response to exertion.
- Stable biomarker levels despite varying activity levels challenge the notion that symptoms arise from deconditioning and question the effectiveness of graded exercise therapy.
- Investigators emphasize that findings remain preliminary and further studies are needed to confirm whether a reliable blood test can be developed.